Icon
+91 94997 68112
Login Register

RADICAVA (nda209176)- (30MG/100ML (0.3MG/ML),60MG/100ML (0.6MG/ML))

EDARAVONE MITSUBISHI TANABE
30MG/100ML (0.3MG/ML),60MG/100ML (0.6MG/ML)
No No
2020-Nov-13 2022-May-05
2024-May-05 None
None No
RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
4 3 2
Total Other Developers 24
Drugs with Suitability No
30MG/100ML (0.3MG/ML) ** ** - - -
60MG/100ML (0.6MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.